Global Fluid Management Systems Market Overview
The Fluid Management Systems Market Size was valued at USD 9.6 Billion in 2023. The Fluid Management Systems Market industry is projected to grow from USD 10.9 Billion in 2024 to USD 27.38 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 14.00% during the forecast period (2024 - 2032). The rising acceptance of minimally invasive surgeries, advancements in fluid management technologies, increased government support for nonsurgical procedures, expansion of the ESRD patient population, and escalating investments in endoscopy and laparoscopy facilities on a scale are expected to be significant market drivers for the Fluid Management Systems Market.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Fluid Management Systems Market Trends
- The rising burden of chronic diseases and rising demand for minimally invasive procedures are driving the market growth.
Market CAGR for Fluid Management Systems is driven by the rising burden of chronic diseases and Rising Demand for Minimally Invasive Procedures. For instance, the report published by the International Diabetes Federation in November 2021 points out that there are about 140,869.6 Chinese who are age groups between 20 and 79 suffering from diabetes ly. In addition, it reported that, as of 2021, the prevalence rate of diabetes in China is around 10.6%. This was, however, in contrast to 2011, when the prevalence rate was 8.8%. Moreover, the National Health Survey 2021 research also stated that there were about 72,839.5 people who were undiagnosed diabetes in 2021. In comparison to this, Shields from the Center for Disease Control and Prevention (CDC) published an article in 2020 showing that about 5.0% of the elderly had been recognized as a patient with emphysema, chronic bronchitis, or COPD (Chronic Obstructive Pulmonary Disease). Concurrently, the Chronic obstructive pulmonary disease (COPD) Prevalence in people aged forty or more is 10.1%, according to the journal published in January 2022 by the National Center for Biotechnology Information. This is also expected to create positive impacts on the growth of the fluid management systems industry within the given forecast period.
The main advantages of minimally invasive products are low cost, safety, quick pain recovery, and less risk of complications. On the 25th of March 2016, researchers at John Hopkins revealed a comprehensive study about the relative cost difference between traditional open surgery (Trad OS) and minimally invasive surgery (MIS). The research reports that hospitals could become more effective in preventing surgery-related complications, and this would lead to USD 280 to USD 340 million of the total yearly funds saved by adopting minimally invasive products. The reduced cost is one of the main reasons that the market works at a good price. As a result, it is anticipated that throughout the projection period, demand for the Fluid Management Systems Market will increase due to the rising burden of chronic diseases and Rising Demand for Minimally Invasive Procedures. Thus, driving the Fluid Management Systems Market revenue.
Fluid Management Systems Market Segment Insights
Fluid Management Systems Market Product Insights
The Fluid Management Systems Market segmentation, based on Product, includes Fluid Management Systems and Fluid Management Disposables & Accessories. The fluid management systems segment dominated the market, accounting for 58% of market revenue. This predominance is explained by the high cost of diagnosis, monitoring, and treatment systems in contrast with the price of accessories & consumables. The standalone single-line fluid management unit is equipped with insufflators, fluid warming devices, dialyzers, and ports, among the other components. The aging population, the extensive need for minimally invasive procedures, the expansion in research and development, and technological progress are some of the influential factors driving the market expansion of this field.
Fluid Management Systems Market Application Insights
The Fluid Management Systems Market segmentation, based on Application, includes Urology and Nephrology, Laparoscopy, Gastroenterology, Gynecology / Obstetrics, Bronchoscopy, Arthroscopy, Cardiology, Neurology, Otoscopy, Dentistry, and Other Applications. The cardiology segment dominated the market, accounting for 58% of market revenue. As the demand for minimally invasive procedures increases, cardiology appreciates the smaller incisions and recovery times, reduced risk of complications, and shorter hospital stays, which are the advantages of minimally invasive surgery compared to traditional open operations. Minimally invasive methods of management, such as percutaneous coronary interventions (PCIs) and transcatheter aortic valve replacement (TAVR), emphasize the need for fluid balance to be controlled to maintain hemodynamic stability and ensure optimal outcomes for patients.
Fluid Management Systems Market End User Insights
The Fluid Management Systems Market segmentation, based on End Users, includes Hospitals, Dialysis Centers, Ambulatory Surgical Centers, and Other End Users. The hospital segment dominated the market, accounting for 60% of market revenue. The segment of hospitals was the most dominant owing to the increasing number of endoscopic procedures in hospitals and the increase in the prevalence of chronic diseases. They are equipped with various fluid handling systems.
Figure 1: Fluid Management Systems Market, by End User, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Fluid Management Systems Market Regional Insights
By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The anticipated expansion of the Fluid Management Systems market in North America can be attributed to several key factors. Hypertension is one of the leading causes of cardiovascular diseases. According to the CDC's 2020 report, approximately half (47.0%) of the adult population in the United States has hypertension - defined as systolic blood pressure greater than 130 or 80 mmHg or taking blood pressure medication - substantiating it to be one of the common health issues in the nation. North American market share is growing since market participants are engaging in product launches using the latest technology. For instance, In 2016, the renal therapeutic division of B. Braun introduced to the U.S. market a high-performance dialyzer named Xevonta, which is a next-generation device for toxins clearance.
Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, and South Korea.
Figure 2: Fluid Management Systems Market Share By Region 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe's Fluid Management Systems Market accounts for the second-largest market share, as specialized fluid management systems have seen a spike in demand in the healthcare market. That demand has been quickest in surgical fields, e.g., minimally invasive surgeries, dialysis, and infusion therapy. In EU countries, Germany (12.8 %) and France (12.2 %) set the leading healthcare expenses relative to GDP in 2020. Hospitals were the most important healthcare providers when it came to expenditure, accounting for approximately one-third (37.4%) of all healthcare spending in the EU in 2020. Ambulatory healthcare providers (24.8 percent), medical goods retailers, and other medical equipment providers (16.7 percent) were the healthcare service sectors most provided after hospitals in expenditure terms. With healthcare facilities trying to improve patient care safety and operation efficiency, they are gradually beginning to adopt advanced fluid management systems to achieve these goals. Further, the German Fluid Management Systems Market held the largest market share, and the UK Fluid Management Systems Market was the fastest-growing market in the European region.
The Asia-Pacific Fluid Management Systems Market is expected to grow at the fastest CAGR from 2024 to 2032. Asia-Pacific fluid management devices market potential is poised to increase as a result of robust economic growth and low operating costs. The rising incidence of chronic diseases such as cancer and orthopedic diseases, accompanied by an aging population, is a major driving factor for the market growth in this region. Over the period- from 2000 to 2018, the population aged 60 years and older has increased from 126 million to 249 million, and in 2022, they reached 280 million. The population of the elderly continued to rise along the way: from ten percent in 2000 to nineteen-point eight percent in 2022. Moreover, China’s Fluid Management Systems Market held the largest market share, and the Indian Fluid Management Systems Market was the fastest-growing market in the Asia-Pacific region.
Fluid Management Systems Market Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development to expand their product lines, which will help the Fluid Management Systems market grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Fluid Management Systems industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Fluid Management Systems industry to benefit clients and increase the market sector. In recent years, the Fluid Management Systems industry has offered some of the most significant advantages to the medical and healthcare sectors. Major players in the Fluid Management Systems Market, including Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (Germany), Stryker Corporation (US), Olympus Corporation (Japan), Medline Industries, Inc. (US), KARL STORZ GmbH & Co. KG (Germany), Ecolab Inc. (US), Smiths Medical (UK) are attempting to increase market demand by investing in research and development operations.
Fresenius Medical Care AG & Co. KGaA has multiple segments of the dialysis business. It offers hemodialysis devices and consumables to people consistently experiencing kidney failure. The company manufactures and Commercializes a variety of dialysis systems, devices, and disposable products. In addition to all these offerings, Fresenius Medica Care also provides coordinated care services, including pharmacy services, vascular, kidney, and blood vessels specialists, non-dialysis laboratory services, hospitalists and intensivists, and health plan service and urgent care services. The company provides dialysis facilities at its hospital and sells its goods to different dialysis service providers. It functions by designating its subsidiaries in Europe, the Middle East, Africa, the Americas, and Asia Pacific. Fresenius Medical Care is based in München, Germany. In February 2019, Frescencia Medical Care (Germany) bought NxStage Medical of Inc. (a US home dialysis leader). The purpose of acquiring this company is to grow the dialysis segment in which the company is already involved.
Baxter International Inc. (Baxter) is a company that offers a variety of health products. The products and services provided by this company cover acute and chronic kidney failure dialysis, sterile intravenous solutions, generic injectable pharmaceuticals, parenteral nutrition therapies, infusion systems and devices, anesthetics of inhalation, and surgical site control and sealants. The same products of the company are being marketed at hospitals, rehabilitation centers, kidney dialysis centers, nursing homes, and also to the patients who are at their homes. Baxter markets and sells the products either by dealing with independent distributors or directly by drug wholesalers, specialty pharmacies, and alternative site workers. It is present in North and South America, the Middle East, Africa, Europe and Asia-Pacific. Baxter's main head offices are in Deerfield, Illinois, the US.
Key companies in the Fluid Management Systems Market include
- Fresenius Medical Care AG & Co. KGaA (Germany)
- Baxter International Inc. (US)
- Cardinal Health, Inc. (US)
- Braun Melsungen AG (Germany)
- Stryker Corporation (US)
- Olympus Corporation (Japan)
- Medline Industries, Inc. (US)
- KARL STORZ GmbH & Co. KG (Germany)
- Ecolab Inc. (US)
- Smith’s Medical (UK)
Fluid Management Systems Industry Developments
December 2020: Medtronic (Ireland) launched the Carpediem System, an acute dialysis machine tailored for pediatric and neonatal patients, including the dialyzer, to the US market.
June 2020: Fresenius Medical Care (Germany) announced plans to establish over 100 new transitional care unit (TCU) centers across the US. These centers aim to assist individuals newly diagnosed with kidney failure by providing education on treatment choices, including home dialysis, and fostering greater patient autonomy in care management.
Fluid Management Systems Market Segmentation
Fluid Management Systems Market Product Outlook
- Fluid Management Systems
- Fluid Management Disposables & Accessories
Fluid Management Systems Market Application Outlook
- Urology and Nephrology
- Laparoscopy
- Gastroenterology
- Gynecology / Obstetrics
- Bronchoscopy
- Arthroscopy
- Cardiology
- Neurology
- Otoscopy
- Dentistry
- Other Applications
Fluid Management Systems Market End User Outlook
- Hospitals
- Dialysis Centers
- Ambulatory Surgical Centers
- Other End Users
Fluid Management Systems Market Regional Outlook
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Report Attribute/Metric |
Details |
Market Size 2023 |
USD 9.6 Billion |
Market Size 2024 |
USD 10.9 Billion |
Market Size 2032 |
USD 27.38 Billion |
Compound Annual Growth Rate (CAGR) |
14.00% (2024-2032) |
Base Year |
2023 |
Market Forecast Period |
2024-2032 |
Historical Data |
2019- 2022 |
Market Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Product, Application, End User, and Region |
Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
Countries Covered |
The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea |
Key Companies Profiled |
Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (Germany), Stryker Corporation (US), Olympus Corporation (Japan), Medline Industries, Inc. (US), KARL STORZ GmbH & Co. KG (Germany), Ecolab Inc. (US), Smiths Medical (UK) |
Key Market Opportunities |
A growing number of hospitals and investments in endoscopy and laparoscopy facilities |
Key Market Dynamics |
Rise in the number of minimally invasive surgeries |
Frequently Asked Questions (FAQ) :
The Fluid Management Systems Market size was valued at USD 9.6 Billion in 2023.
The Fluid Management Systems Market is projected to grow at a CAGR of 14.00% during the forecast period, 2024-2032.
North America had the largest share of the global market.
The key players in the market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (Germany), Stryker Corporation (US), Olympus Corporation (Japan), Medline Industries, Inc. (US), KARL STORZ GmbH & Co. KG (Germany), Ecolab Inc. (US), Smiths Medical (UK)
Cardiology segment dominated the market in 2023.
The hospitals segment had the largest share in the global market.